REGISTRATION DETAILS

R&D Company Rate 
$995 USD / 7,600 RMB (Early Bird R&D Rate before August 30, 2024)
$1,295 USD / 9,900 RMB (R&D Rate after August 30, 2024)
If your company has a drug or device in preclinical/clinical development, or a product already on the market, you are eligible for the R&D rate.

R&D Company Group Rates* 
*If you are an R&D Company and your team is interested in sending multiple attendees, please email us at [email protected] to register as a group. The group discounts are listed below.

Group Rate A (2 to 4 Attendees) $750 USD / 5,700 RMB per attendee
Group Rate B (5+ Attendees) $585 USD / 4,500 RMB per attendee

China Emerging Company Rate 
$500 USD / 3,800 RMB

If your company is a new/small/developing domestic Chinese company, you may be eligible for a special discounted rate. Those eligible for this special rate include Founders, CEOs, CFOs, and other senior management of China-based healthcare operating companies in the products/services areas in the "new," "young" or "start-up" phase. This rate excludes consultants, advisers, established companies, etc. China Emerging Rate is subject to approval by Lychee Group. Please email Eric Lu at [email protected] to confirm your eligibility. If approved, you will then be sent the required code to enter that will enable you to register at this special rate.

Government employees and those working at academic institutions are also eligible for this rate. Workshops are included with this rate.

Standard Rate 
$1,395 USD / 10,650 RMB (Early Bird Standard Rate before August 30, 2024)
$1,695 USD / 12,990 RMB (Standard Rate after August 30, 2024)

If you are not eligible for the R&D Rate or the China Emerging Company Rate option listed below, you must select Standard Attendee when registering.